Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             285 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A behavioral approach to the neurobiology of schizophrenia Gaebel, W.
1991
4 3 p. 257-258
2 p.
artikel
2 A carbamazepine augmentation trial in chronic nonresponsive schizophrenia Meszaros, K.
1991
4 3 p. 291-
1 p.
artikel
3 A comparison of two short term models for multiple family group treatment Lukens, E.P.
1991
4 3 p. 306-
1 p.
artikel
4 Activation tasks in neuroleptic-induced akathisia Fleischhacker, W.W.
1991
4 3 p. 363-
1 p.
artikel
5 Acute extrapyramidal syndromes: Clinical characteristics implicate different pathophysiologies Casey, D.E.
1991
4 3 p. 361-
1 p.
artikel
6 Adjunctive neuropsychological remediation in psychiatric rehabilitation: Program description and priliminary data Jaeger, J.
1991
4 3 p. 304-305
2 p.
artikel
7 Adult neuropsychological and brain morphological findings in a sample of schizophrenic patients studied with home movies made as children Lewine, R.
1991
4 3 p. 387-
1 p.
artikel
8 Age dependent changes in dopamine transporter binding and its relevance to schizophrenia Hitri, A.
1991
4 3 p. 346-
1 p.
artikel
9 Aggressive behavior and the use of seclusion/restraint in chronic schizophrenic patients Dickerson, F.
1991
4 3 p. 302-
1 p.
artikel
10 A magnetic resonance imaging study comparing treatment-refractory and treatment-responsive schizophrenics Miller, D.D.
1991
4 3 p. 406-
1 p.
artikel
11 Amphetamine: clinical response of chronic schizophrenics to a single oral dose Bigelow, L.B.
1991
4 3 p. 313-
1 p.
artikel
12 Analysis of cerebrospinal fluid monoamines in schizophrenic patients on and off neuroleptic treatment and compared with healthy controls Kirch, D.G.
1991
4 3 p. 349-
1 p.
artikel
13 An animal model of the schizophrenic hippocampus: an attempt to influence fetal hippocampal development by means of maternal viral infection Scheibel, A.B.
1991
4 3 p. 359-360
2 p.
artikel
14 An autoradiographic study of cholecystokinin receptors in the temporal lobe in post-mortem schizophrenic brains Kerwin, R.W.
1991
4 3 p. 348-349
2 p.
artikel
15 An electrophysiological investigation of the mechanism of action of the 5-HT2 antagonists ritanserin and MDL 28,133A on amphetamine induced slowing of A10 dopamine neurons Sorensen, S.M.
1991
4 3 p. 337-338
2 p.
artikel
16 Antibodies from patients with schizophrenia recognize a 68 kD neuronal protein Kilidireas, C.
1991
4 3 p. 371-372
2 p.
artikel
17 A phenomenological test of the validity of the deficit syndrome Kirkpatrick, B.
1991
4 3 p. 262-
1 p.
artikel
18 A preparation and fixation technique suitable for quantitative immunohistochemistry and autoradiography of human brain tissue Potkin, S.G.
1991
4 3 p. 359-
1 p.
artikel
19 Assessment and evaluation of extrapyramidal symptoms of remoxipride and haloperidol in acute treatment of schizophrenia Blomqvist, M.
1991
4 3 p. 314-
1 p.
artikel
20 Association of pineal gland calcification with neuroleptic dose in chronic schizophrenia Sandyk, R.
1991
4 3 p. 294-
1 p.
artikel
21 Asymmetries in attentional filtering in left and right visual fields in schizophrenic patients Wigal, S.B.
1991
4 3 p. 396-
1 p.
artikel
22 A trial of enriched social treatments: Design and outcome Monroe-Blum, H.
1991
4 3 p. 306-307
2 p.
artikel
23 A trial of L-dopa and molindone in schizophrenia Clardy, J.
1991
4 3 p. 315-316
2 p.
artikel
24 Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia Sandyk, R.
1991
4 3 p. 411-412
2 p.
artikel
25 A twin study of prenatal injury markers in psychosis: Timing the insult Bracha, U.S.
1991
4 3 p. 250-
1 p.
artikel
26 Auditory P300 topography and frontal activation in schizophrenia Merrin, E.L.
1991
4 3 p. 335-
1 p.
artikel
27 Axis II personality features and disorder in subjects in the New York high-risk project Squires-Wheeler, E.
1991
4 3 p. 284-285
2 p.
artikel
28 Backward masking deficits in schizophrenia: Implicating a mechanism Green, M.F.
1991
4 3 p. 384-
1 p.
artikel
29 Behavioral and biochemical effects of methylphenidate infusion in schizophrenic and nonschizophrenic patients Sharma, R.P.
1991
4 3 p. 356-
1 p.
artikel
30 Behavioral and hormonal response to serotonergic challenge in chronic schizophrenia patients Lindenmayer, J.-P.
1991
4 3 p. 351-
1 p.
artikel
31 Benzodiazepine responsivity in schizophrenia Wolkowitz, O.M.
1991
4 3 p. 296-
1 p.
artikel
32 Biochemical pharmacology of the atypical neuroleptic remoxipride Kohler, C.
1991
4 3 p. 319-
1 p.
artikel
33 Biologic indices of heterogeneity in schizophrenia: Relationship to psychopathology and treatment outcome Lieberman, J.
1991
4 3 p. 289-290
2 p.
artikel
34 Borna disease virus and schizophrenia: Preliminary results Waltrip, R.W.
1991
4 3 p. 374-
1 p.
artikel
35 BPRS symptom factors and sleep variables in schizophrenia Benson, K.L.
1991
4 3 p. 329-330
2 p.
artikel
36 Brain morphology in first episode schizophrenia Lieberman, J.
1991
4 3 p. 387-388
2 p.
artikel
37 Catecholamine metabolism in psychotic/schizophrenic patients Maas, J.A.
1991
4 3 p. 352-
1 p.
artikel
38 Central D2 dopaminergic receptor status in treatment responsive and treatment resistant schizophrenic patients as measured by 123I-IBZM single photon emission tomography (SPET) Pilowsky, L.S.
1991
4 3 p. 410-
1 p.
artikel
39 Cerebral atrophy, signal hyperintensities and ventricular volume in schizophrenia on MRI: Relationship to the presence or absence of tardive dyskinesia Waddington, J.L.
1991
4 3 p. 369-
1 p.
artikel
40 Cerebrospinal fluid concentrations of dopamine and serotonin metabolites in patients with schizophrenia and schizoaffective disorder: The significance of positive and negative symptoms Risby, E.D.
1991
4 3 p. 355-
1 p.
artikel
41 Changes of the mRNAs for two dopamine D2 receptor isoforms in rat brain by haloperidol or methamphetamine treatment Sora, I.
1991
4 3 p. 284-
1 p.
artikel
42 Characteristics of some auditory evoked potential (AEP) and field (AEF) responses (100 ms) in schizophrenia Reeve, A.
1991
4 3 p. 336-
1 p.
artikel
43 Characterization of genetically transmitted schizophrenia in Danish adoptees Ingraham, L.J.
1991
4 3 p. 279-280
2 p.
artikel
44 Characterization of positive and negative symptoms in the early course of schizophrenia Ventura, J.
1991
4 3 p. 270-271
2 p.
artikel
45 Chromosomal aberrations and schizophrenia Bassett, A.S.
1991
4 3 p. 248-249
2 p.
artikel
46 Chronic clozapine, but not typical antipsychotic agents, increase lymphocyte glucocorticoid receptors in schizophrenics Lowy, M.T.
1991
4 3 p. 351-352
2 p.
artikel
47 Chronicity, negative symptoms and cognitive disorders of psychotic patients: Implications for treatment Kuipers, T.
1991
4 3 p. 262-263
2 p.
artikel
48 Clinical and immunological correlates of antibrain IgG autoantibodies in schizophrenic patients Ganguli, R.
1991
4 3 p. 371-
1 p.
artikel
49 Clinical correlates of plasma HVA during neuroleptic withdrawal Saltz, B.L.
1991
4 3 p. 293-294
2 p.
artikel
50 Clozapine and tardive dyskinesia: Prospective data Kane, J.M.
1991
4 3 p. 364-365
2 p.
artikel
51 Clozapine treatment in schizophrenic outpatients: Preliminary results from a double-blind efficacy study Breier, A.
1991
4 3 p. 315-
1 p.
artikel
52 Cognitive deficits underlying verbal memory function in schizophrenic patients and controls Yurgelun-Todd, D.A.
1991
4 3 p. 396-397
2 p.
artikel
53 Cognitive impairment and symptomatology associated with postdexamethasone cortisol concentrations in unmedicated schizophrenic patients Newcomer, J.W.
1991
4 3 p. 353-
1 p.
artikel
54 Comparison methods of quantification of spect brain images in psychiatric research Fenn, D.S.
1991
4 3 p. 403-
1 p.
artikel
55 Complications of pregnancy and delivery in relation to psychosis in adult life: A study using the perinatal mortality survey Crow, T.J.
1991
4 3 p. 253-
1 p.
artikel
56 Computer assisted volumetric measurements of MR brain images in schizophrenia Shenton, M.E.
1991
4 3 p. 413-
1 p.
artikel
57 Coping behavior in schizophrenic patients in terms of a situation/operation theory of stress and coping Boker, W.
1991
4 3 p. 300-
1 p.
artikel
58 Correlates of course and outcome in first-episode schizophrenia Loebel, A.
1991
4 3 p. 290-
1 p.
artikel
59 Correlates of suicidal ideation in post-psychotic depression Siris, S.G.
1991
4 3 p. 378-
1 p.
artikel
60 Correlation between changes in neurotransmitter receptor densities and chronic GABA agonist actions on haloperidol-induced vacuous chewing movements Shirakawa, O.
1991
4 3 p. 366-367
2 p.
artikel
61 Critical issues in the study of prepulse inhibition of acoustic startle: A measure of sensory gating related to mesolimbic dopamine activity Schwarzkopf, S.B.
1991
4 3 p. 392-
1 p.
artikel
62 CSF neurotransmitter changes during clozapine pharmacotherapy in schizophrenia Risch, S.C.
1991
4 3 p. 324-325
2 p.
artikel
63 Decreased substance P- and increased calcitonin gene-related peptide immunoreactivities in the cerebrospinal fluid of drug-naive schizophrenic patients Fleischhacker, W.W.
1991
4 3 p. 344-345
2 p.
artikel
64 Delta sleep inducing peptide-like immunoreactivity and sleep EEG results in schizophrenia Peters, J.L.
1991
4 3 p. 336-
1 p.
artikel
65 Dementia in elderly schizophrenic patients Davidson, M.
1991
4 3 p. 275-276
2 p.
artikel
66 Deterioration in premorbid functioning: A developmental model of negative symptoms Kelly, M.E.
1991
4 3 p. 261-
1 p.
artikel
67 Development of cognitive and electrophysiological measures of selective attention for genetic linkage studies of schizophrenia Emmerson, R.Y.
1991
4 3 p. 255-
1 p.
artikel
68 Development of drug-induced parkinsonism in elderly individuals receiving neuroleptics for the first time Saltz, B.L.
1991
4 3 p. 365-366
2 p.
artikel
69 Diagnosis of Blacks in a state system Lawson, W.B.
1991
4 3 p. 263-
1 p.
artikel
70 Differential effect of clozapine on psychopathology and cognitive dysfunction in treatment-resistant schizophrenics Kenny, J.T.
1991
4 3 p. 386-387
2 p.
artikel
71 Dimensionality of a neuropsychiatric soft sign battery Faber, R.
1991
4 3 p. 382-383
2 p.
artikel
72 Discriminating characteristics between schizophrenic and “schizoaffective” patients Beasley, L.
1991
4 3 p. 299-
1 p.
artikel
73 Disengagement of attention in schizophrenia Strauss, M.E.
1991
4 3 p. 394-
1 p.
artikel
74 Distribution of dopamine D-2 receptors in the monkey and human neocortex Lidow, M.S.
1991
4 3 p. 350-351
2 p.
artikel
75 Dopamine (D2) agonist receptor binding properties of [3H]U-86170 Lahti, R.A.
1991
4 3 p. 319-320
2 p.
artikel
76 Dopamine-hydroxylase-like immunoreactivity in schizophrenia: Premorbid functioning and drug response van Kammen, D.P.
1991
4 3 p. 356-
1 p.
artikel
77 Editorial acknowledgement Nasrallah, Henry A.
1991
4 3 p. 246-
1 p.
artikel
78 EEG-brain mapping—A useful predictor of the efficiency of neuroleptic therapy in schizophrenic patients Schellenberg, R.
1991
4 3 p. 337-
1 p.
artikel
79 EEG photic driving in chronic PCP users, schizophrenic patients, and normal controls Jin, Y.
1991
4 3 p. 333-334
2 p.
artikel
80 Effect of neuroleptic withdrawal on the relationship of tardive dyskinesia and ventricular enlargement Hoffman, W.F.
1991
4 3 p. 364-
1 p.
artikel
81 Effect of typical and atypical antipsychotic drugs on the in vivo binding of [3H]N-methyl-spiperone to serotonin-2 and dopamine-2 receptors in rat brain Stockmeier, C.A.
1991
4 3 p. 326-327
2 p.
artikel
82 Effects of clozapine on cognition in patients with schizophrenia Greenberg, R.
1991
4 3 p. 385-
1 p.
artikel
83 Effects of famotidine, a histamine H2-receptor antagonist, on negative symptoms of schizophrenia Kaminski, R.
1991
4 3 p. 318-319
2 p.
artikel
84 Effects of leucotomy lesion size and location on personality and intellect Swayze II, V.W.
1991
4 3 p. 395-
1 p.
artikel
85 Effects of methamphetamine and MK-801 on dopamine in the striatum of awake rats: In vivo brain microdialysis and behavioral measures Marshall, J.F.
1991
4 3 p. 352-
1 p.
artikel
86 Efficacy and tolerability of clozapine in the treatment of 425 schizophrenic patients Naber, D.
1991
4 3 p. 322-323
2 p.
artikel
87 Efficacy and tolerability of the partial dopamine agonist SDZ HDC 912 in the treatment of schizophrenia Naber, D.
1991
4 3 p. 323-
1 p.
artikel
88 Elevated central levels of interleukin-2 in drug-free schizophrenic patients Licinio, J.
1991
4 3 p. 372-
1 p.
artikel
89 Epidemiology of schizophrenia in rural Ireland: Evidence for geographical variations in prevalence Youssef, H.A.
1991
4 3 p. 271-
1 p.
artikel
90 Ethnic differences in schizophrenia Mance, R.
1991
4 3 p. 264-
1 p.
artikel
91 Evaluating neuropsychological impairments in adult schizophrenic inpatients with a childhood age of onset: A preliminary report Hoff, A.L.
1991
4 3 p. 386-
1 p.
artikel
92 Evidence for an early antipsychotic effect of neuroleptics in patients with chronic schizophrenia Stern, R.G.
1991
4 3 p. 294-295
2 p.
artikel
93 Evidence for structural and functional pre-frontal impairments in schizophrenia Raine, A.
1991
4 3 p. 411-
1 p.
artikel
94 Evidence of early brain changes in subgroup of twins with schizophrenia Torrey, E.F.
1991
4 3 p. 285-
1 p.
artikel
95 Expressed Emotion (EE) and the targeted medication approach Hanlon, T.E.
1991
4 3 p. 304-
1 p.
artikel
96 Factors associated with medication noncompliance in schizophrenic patients Albus, M.
1991
4 3 p. 287-
1 p.
artikel
97 Family interaction vs. individual psychopathology Goldstein, M.J.
1991
4 3 p. 303-304
2 p.
artikel
98 Family involvement in the management of schizophrenia-evaluation of a new model Katsching, H.
1991
4 3 p. 305-306
2 p.
artikel
99 Forms of memory failure in schizophrenia Gold, J.M.
1991
4 3 p. 383-384
2 p.
artikel
100 From antibody to gene in schizophrenia: Methodology and progress report Honer, W.G.
1991
4 3 p. 278-279
2 p.
artikel
101 Frontal and right-left differences in schizophrenic vs normal subjects: A magnetic resonance brain imaging (MRI) study DeMyer, M.K.
1991
4 3 p. 402-403
2 p.
artikel
102 Functional brain topography by means of EEG mapping: Distinction of diagnosis and state in mental illness by means of a geometrical reconnaissance task Gallhofer, B.
1991
4 3 p. 332-333
2 p.
artikel
103 Functional brain topography by means of EEG mapping: Distinction of diagnosis and state in mental illness by means of an arythmetic task Kunz, S.
1991
4 3 p. 334-
1 p.
artikel
104 Gender differences in cognitive functioning and symptoms in schizophrenics Addington, J.
1991
4 3 p. 273-
1 p.
artikel
105 Gender differences in schizophrenia Haas, G.L.
1991
4 3 p. 277-
1 p.
artikel
106 Gender differences in the familial transmission of schizophrenia Goldstein, J.M.
1991
4 3 p. 258-259
2 p.
artikel
107 Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia Childers, S.E.
1991
4 3 p. 252-
1 p.
artikel
108 Genetic linkage analysis study of schizophrenia in Canadian families: Clinical assessment results Bassett, A.S.
1991
4 3 p. 249-
1 p.
artikel
109 Genetic linkage studies in schizophrenia using (CA)n repeat polymorphisms Polymeropoulos, M.H.
1991
4 3 p. 283-
1 p.
artikel
110 Genetic versus environmental rorschach variables in the Finnish adoptive family study of schizophrenia Wahlberg, K.-E.
1991
4 3 p. 309-310
2 p.
artikel
111 Haloperidol kinetics and clinical response Conley, R.
1991
4 3 p. 287-
1 p.
artikel
112 Hard neurologic signs and obstetric complications: Evidence for etiologic roles in schizophrenia Kinney, D.K.
1991
4 3 p. 261-262
2 p.
artikel
113 Heart rate variability in schizophrenia Dalack, G.W.
1991
4 3 p. 332-
1 p.
artikel
114 Ibotenic acid or ablation lesions of the frontal cortex do not alter the density or the affinity of D1 and D2 receptors in the corpus striatum or nucleus accumbens Jaskiw, G.E.
1991
4 3 p. 346-347
2 p.
artikel
115 Identification of subgroups of poorly responsive schizophrenics Raymond, R.
1991
4 3 p. 324-
1 p.
artikel
116 Immunohistochemistry of neuropeptides in tardive dyskinesia Falkai, P.
1991
4 3 p. 362-
1 p.
artikel
117 Impaired implicit memory in schizophrenia: A selective deficit? Heinrichs, R.W.
1991
4 3 p. 385-
1 p.
artikel
118 Impaired social functioning and schizophrenia: A familial association? Brunke, J.J.
1991
4 3 p. 250-251
2 p.
artikel
119 Implicit memory function in schizophrenia Randolph, C.
1991
4 3 p. 391-
1 p.
artikel
120 Implicit versus explicit memory in schizophrenia Myles-Worsley, M.
1991
4 3 p. 389-
1 p.
artikel
121 Increased percentages of T lymphocytes in the CSF of schizophrenic patients McAllister, C.G.
1991
4 3 p. 373-
1 p.
artikel
122 Index of first authors 1991
4 3 p. 417-420
4 p.
artikel
123 Information processing impairment in Finnish adopted-away offspring of schizophrenic mothers and control mothers Moring, J.
1991
4 3 p. 282-
1 p.
artikel
124 Initial experience with clozapine in Oregon's State Hospitals Wilson, W.H.
1991
4 3 p. 327-328
2 p.
artikel
125 Inside the black box called “expressed emotion”: A theoretical critique of the construct in psychiatric research Jenkins, J.H.
1991
4 3 p. 305-
1 p.
artikel
126 Insight and its related factors of chronic schizophrenic patients Takai, A.
1991
4 3 p. 309-
1 p.
artikel
127 Investigations of abnormal selective attention as a possible vulnerability marker for schizophrenia Myles-Worsley, M.
1991
4 3 p. 389-390
2 p.
artikel
128 Is delusional disorder different from schizophrenia? Jeste, D.V.
1991
4 3 p. 260-
1 p.
artikel
129 Kraepelinian schizophrenia: A replication in an independent sample Frecska, E.
1991
4 3 p. 257-
1 p.
artikel
130 Latent inhibition-based animal models: Implications of effects of phencyclidine and clozapine Christison, G.W.
1991
4 3 p. 331-332
2 p.
artikel
131 Lateral and third ventricular volumes in schizophrenics and their siblings: Effect of spectrum diagnosis Olson, S.C.
1991
4 3 p. 407-408
2 p.
artikel
132 Lateralized differences in reaction time in schizophrenic patients Wigal, S.B.
1991
4 3 p. 396-
1 p.
artikel
133 Left-handedness in schizophrenia is associated with increased impairment on the Luria-Nebraska neuropsychological battery Faustman, W.O.
1991
4 3 p. 383-
1 p.
artikel
134 Life events and prodromal symptoms in schizophrenia Herz, M.I.
1991
4 3 p. 289-
1 p.
artikel
135 Limbic system morphology in schizophrenia: A comparison of new post mortem and MRI data Bogerts, B.
1991
4 3 p. 400-
1 p.
artikel
136 Linkage analysis of six schizophrenia pedigrees with 150 DNA markers Byerley, W.
1991
4 3 p. 274-275
2 p.
artikel
137 Linkage map of schizophrenia 11q Gill, M.
1991
4 3 p. 258-
1 p.
artikel
138 Linkage studies of two new genes of neuropsychiatric interest Kennedy, J.L.
1991
4 3 p. 280-
1 p.
artikel
139 Lithium carbonate added to neuroleptics in treatment refractory schizophrenia Meszaros, K.
1991
4 3 p. 291-292
2 p.
artikel
140 Lithium in combination with perphenazine: Effect on plasma monoamine metabolities Bowers, M.B.
1991
4 3 p. 341-342
2 p.
artikel
141 Low amounts of the α subunit of GTP-binding protein Go in orbital frontal cortex of schizophrenic brain: Biochemical evidence of the hypofrontality hypothesis of schizophrenia Okada, F.
1991
4 3 p. 353-354
2 p.
artikel
142 Maintenance of grip-induced muscle tension as a marker variable in schizophrenia Rosen, A.J.
1991
4 3 p. 391-392
2 p.
artikel
143 MCPP effects in schizophrenic patients before and after typical and atypical neuroleptic treatment Krystal, J.H.
1991
4 3 p. 350-
1 p.
artikel
144 Measures of shifts in covert visual attention and eye movements in schizophrenia Moran, M.
1991
4 3 p. 388-389
2 p.
artikel
145 Measuring the character of community treatments for schizophrenics: Implications for efficacy and heterogeneity Brekke, J.S.
1991
4 3 p. 300-301
2 p.
artikel
146 Memory, frontal and other cognitive impairments in schizophrenia—A neuropsychological study McKenna, P.J.
1991
4 3 p. 388-
1 p.
artikel
147 Memory function in monozygotic twins discordant for schizophrenia Goldberg, T.E.
1991
4 3 p. 384-
1 p.
artikel
148 Mesial temporal volume changes on MRI in schizophrenic and affective patients Pearlson, G.D.
1991
4 3 p. 409-
1 p.
artikel
149 Monitoring service implementation in controlled services trials Hargreaves, W.A.
1991
4 3 p. 289-
1 p.
artikel
150 Morphometric study of prefrontal cortex and limbic structures in schizophrenia Breier, A.
1991
4 3 p. 400-
1 p.
artikel
151 MRI and PET studies in late life-onset schizophrenics Pearlson, G.D.
1991
4 3 p. 409-410
2 p.
artikel
152 MRI findings as a predictor of clozapine response Jewart, R.D.
1991
4 3 p. 406-
1 p.
artikel
153 99m-technetium single photon emission imaging in chronic schizophrenia and healthy volunteers Ford, R.
1991
4 3 p. 404-
1 p.
artikel
154 Negative schizophrenia as a variant of parkinsonism Sandyk, R.
1991
4 3 p. 266-267
2 p.
artikel
155 Negative symptoms, neuropsychological findings, and ventricular enlargement in schizophrenia DeQuardo, J.R.
1991
4 3 p. 254-255
2 p.
artikel
156 Neurodevelopmental indicators of vulnerability for schizophrenia Walker, E.F.
1991
4 3 p. 285-286
2 p.
artikel
157 Neuroendocrine determinants of disturbed water regulation in schizophrenia Lawson, W.B.
1991
4 3 p. 377-378
2 p.
artikel
158 Neuroendocrinological and neurochemical effects of the sigma ‘antagonist’ BMY 14802 Gudelsky, G.A.
1991
4 3 p. 318-
1 p.
artikel
159 Neuroleptic-induced changes in gene expression in rat brain Cohen, B.M.
1991
4 3 p. 342-343
2 p.
artikel
160 Neurological soft signs in schizophrenic patients Mohr, F.
1991
4 3 p. 264-265
2 p.
artikel
161 Neurologic sequelae of psychogenic polydipsia Conley, R.
1991
4 3 p. 376-
1 p.
artikel
162 Neuropeptide Y like immunoreactivity in schizophrenia: Relationships with clinical measures Peters, J.
1991
4 3 p. 355-
1 p.
artikel
163 Neuropsychological deficit and symptomatology: Evidence for the heterogeneity of positive symptoms O'Leary, D.S.
1991
4 3 p. 266-
1 p.
artikel
164 Neuropsychological deviations in healthy relatives of schizophrenics Maier, W.
1991
4 3 p. 280-281
2 p.
artikel
165 Neuropsychological impairments are increased in siblings of schizophrenic patients Pogue-Geile, M.F.
1991
4 3 p. 390-
1 p.
artikel
166 Neuropsychological studies of first episode schizophrenia Bilder, R.M.
1991
4 3 p. 381-382
2 p.
artikel
167 Obstetric complications in schizophrenia Davis, O.R.
1991
4 3 p. 254-
1 p.
artikel
168 Oculomotor studies in schizophrenic patients with and without tardive dyskinesia Thaker, G.
1991
4 3 p. 368-
1 p.
artikel
169 Onset and premorbid clinical features of psychosis in the New York high-risk project Bassett, A.S.
1991
4 3 p. 273-274
2 p.
artikel
170 On the clinical profile of remoxipride—Experiences from a clinical trial programme in the acute treatment of schizophrenia Lewander, T.
1991
4 3 p. 321-
1 p.
artikel
171 Pathogenic traits in schizophrenia Spohn, H.E.
1991
4 3 p. 267-268
2 p.
artikel
172 Patterns of psychophysiological and acoustic responses and flat affect in schizophrenia Sison, C.E.
1991
4 3 p. 267-
1 p.
artikel
173 Persistent tardive dyskinesia, caudate atrophy on CT scan, and regional cerebral blood flow findings in schizophrenia Mukherjee, S.
1991
4 3 p. 365-
1 p.
artikel
174 PET studies of frontal lobe function during cognition Berman, K.F.
1991
4 3 p. 399-
1 p.
artikel
175 P300 event-related potential components and axis II-schizophrenia-related features and disorders Squires-Wheeler, E.
1991
4 3 p. 338-
1 p.
artikel
176 Pharmacological evaluation of sertindole: A new atypical neuroleptic Skarsfeldt, T.
1991
4 3 p. 326-
1 p.
artikel
177 Pharmacological properties of SDZ 212-327, a novel antipsychotic candidate Markstein, R.
1991
4 3 p. 322-
1 p.
artikel
178 Phase I trials of BMY 14802, a potential antipsychotic with affinity for sigma binding sites Taylor, D.P.
1991
4 3 p. 327-
1 p.
artikel
179 Phase of illness and suicide in schizophrenia Weiden, P.J.
1991
4 3 p. 379-
1 p.
artikel
180 Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients Van Putten, T.
1991
4 3 p. 295-
1 p.
artikel
181 Plasma homovanillic acid and drug response in schizophrenia Diamond, B.I.
1991
4 3 p. 343-344
2 p.
artikel
182 Plasma homovanillic acid concentrations decrease in responders, but not in non-responders, to neuroleptic treatment Kahn, R.S.
1991
4 3 p. 347-
1 p.
artikel
183 Plasma HVA correlates of attentional performance in unmedicated schizophrenics Harvey, P.D.
1991
4 3 p. 345-346
2 p.
artikel
184 Plasma level determination of haloperidol and reduced haloperidol in patients with treatment refractory schizophrenia by gas chromatography-mass spectrometry Reed, K.L.
1991
4 3 p. 293-
1 p.
artikel
185 Plasma level monitoring of depot neuroleptics Marder, S.R.
1991
4 3 p. 290-291
2 p.
artikel
186 Platelet [3H] dopamine uptake in patients with schizophrenia and non-schizophrenic psychoses: Its relationship to psychopathology Copolov, D.
1991
4 3 p. 343-
1 p.
artikel
187 Polydipsia-hyponatremia: Evidence for specific cerebral structural pathology and implications for the pathophysiology of schizophrenia Kirch, D.G.
1991
4 3 p. 377-
1 p.
artikel
188 Positron emission tomography study of phencyclidine users Wu, J.C.
1991
4 3 p. 415-
1 p.
artikel
189 -3PPP effects on local cerebral glucose utilization in the rat Dixon, L.B.
1991
4 3 p. 316-317
2 p.
artikel
190 Predicting skill acquisition in social skills training for schizophrenia and schizoaffective disorder: The role of memory and symptomatology Mueser, K.T.
1991
4 3 p. 307-308
2 p.
artikel
191 Prefrontal sulcal prominence is inversely related to treatment response to clozapine in schizophrenia Friedman, L.
1991
4 3 p. 317-
1 p.
artikel
192 Prenatal maldevelopment of the palm/thumb in schizophrenia: A monozygotic twins study Bracha, H.S.
1991
4 3 p. 274-
1 p.
artikel
193 Prevalence and risk factors of involuntary movement disorders in a neuroleptic treated population: A comparison between schizophrenic spectrum and non-schizophrenic spectrum patients Smeraldi, E.
1991
4 3 p. 367-368
2 p.
artikel
194 Prolactin bioassay in schizophrenic patients on neuroleptic medication Warner, M.D.
1991
4 3 p. 295-296
2 p.
artikel
195 Psychoactive substance abuse assesment in schizophrenics Dixon, L.B.
1991
4 3 p. 382-
1 p.
artikel
196 Pursuit eye movement dysfunction in schizophrenia: Characteristics of oculomotor disturbance and diagnostic specificity Sweeney, J.A.
1991
4 3 p. 339-
1 p.
artikel
197 Qualitative and quantitative assessment of pre-alpha-cell clusters in the entorhinal cortex of schizophrenics. A neurodevelopmental model of schizophrenia? Falkai, P.
1991
4 3 p. 357-358
2 p.
artikel
198 Quantification of relative haloperidol occupancy and effects in vivo with a simple dual detector probe Jeffries, K.J.
1991
4 3 p. 405-406
2 p.
artikel
199 Quantitative assessment of negative symptoms in chronic schizophrenic patients: Severity, response to treatment, and relationship to positive symptoms Boronow, J.J.
1991
4 3 p. 249-250
2 p.
artikel
200 Quantitative evaluation of astrocyte densities in schizophrenia Falkai, P.
1991
4 3 p. 358-
1 p.
artikel
201 Quantitative features of eye movement dysfunctions in schizophrenics Levy, D.L.
1991
4 3 p. 334-335
2 p.
artikel
202 Reduced cerebral glucose utilization in GABAergic nigral efferent target regions in intranigral isoniazid-induced vacuous chewing movements Bachus, S.E.
1991
4 3 p. 341-
1 p.
artikel
203 Reduced cerebral volume and increased third ventricular volume in schizophrenic patients: A quantitative magnetic resonance imaging study Schwarzkopf, S.B.
1991
4 3 p. 412-
1 p.
artikel
204 Regional brain glucose metabolism in neuroleptic naive first episode and chronic schizophrenic patients and normal controls at rest and after dopamine agonist and antagonist drugs Cleghorn, J.M.
1991
4 3 p. 401-402
2 p.
artikel
205 Regional glucose metabolism assessed by PET as a tool for studying clinical response to typical & atypical neuroleptics Potkin, S.G.
1991
4 3 p. 410-411
2 p.
artikel
206 Registered PET-MRI comparative study of normal volunteers performing a tone discrimination task: the impact of performance error on cortical surface metabolic activity patterns Holcomb, H.H.
1991
4 3 p. 404-405
2 p.
artikel
207 Reliability and validity of a depression scale for schizophrenics Addington, D.
1991
4 3 p. 247-
1 p.
artikel
208 Remoxipride therapy in poorly responsive schizophrenics Conley, R.
1991
4 3 p. 316-
1 p.
artikel
209 Risperidone in the treatment of acute exacerbation of chronic schizophrenia Borison, R.L.
1991
4 3 p. 314-315
2 p.
artikel
210 Sample bias in neurobiological studies of neuroleptic-naive psychotic subjects Keks, N.A.
1991
4 3 p. 260-261
2 p.
artikel
211 S(+)-aporphines as potential limbic-selective antipsychotic agents Baldessarini, R.J.
1991
4 3 p. 312-
1 p.
artikel
212 Schizophrenia and epilepsy: clinical and pathological studies Stevens, J.R.
1991
4 3 p. 373-374
2 p.
artikel
213 Schizophrenia and schizophreniform disorder: Is there a critical difference? Nuechterlein, K.H.
1991
4 3 p. 265-266
2 p.
artikel
214 Schizophrenia and social judgement: Why do schizophrenics get it wrong? Cramer, P.
1991
4 3 p. 301-302
2 p.
artikel
215 Schizophrenia neuroanatomy and theory falsification Carpenter Jr., W.T.
1991
4 3 p. 251-
1 p.
artikel
216 Schizotypal symptoms and information processing deficits in families of schizophrenic patients Steinhauer, S.R.
1991
4 3 p. 393-
1 p.
artikel
217 Second messenger imbalance hypothesis of schizophrenia Kaiya, H.
1991
4 3 p. 348-
1 p.
artikel
218 Segregation analysis of schizophrenia in nine multigenerational pedigrees Plaetke, R.
1991
4 3 p. 283-
1 p.
artikel
219 Sensory gating deficits in neonatally dopamine depleted animals: Evidence for involvement of mesolimbic dopamine supersensitivity Schwarzkopf, S.B.
1991
4 3 p. 392-393
2 p.
artikel
220 Serotonin binding sites and metabolites in the brain of schizophrenic suicide victims Conley, R.
1991
4 3 p. 376-377
2 p.
artikel
221 Serotonin receptor sensitivity in schizophrenia Kahn, R.S.
1991
4 3 p. 347-348
2 p.
artikel
222 Serotonin-2 receptors in the platelets of schizophrenic patients Pandey, G.N.
1991
4 3 p. 354-
1 p.
artikel
223 Serum cholinesterase and REM latency in schizophrenia Keshavan, M.
1991
4 3 p. 334-
1 p.
artikel
224 Should poor premorbid functioning be part of the negative syndrome? Foerster, A.
1991
4 3 p. 256-257
2 p.
artikel
225 Sleep encephalographic studies in schizophrenic patients: Comparison of neuroleptic-naive and previously-medicated patients with healthy controls Taylor, S.F.
1991
4 3 p. 339-340
2 p.
artikel
226 Smoking and tardive dyskinesia Cohen, S.
1991
4 3 p. 361-362
2 p.
artikel
227 Smooth pursuit eye movements in schizophrenia spectrum disorders: Familial vs episodic Thaker, G.
1991
4 3 p. 268-269
2 p.
artikel
228 Social interaction and schizophrenia: Problem, theory, and research Flack Jr., W.F.
1991
4 3 p. 303-
1 p.
artikel
229 Social signalling and schizophrenia: The significance of neurochemical and morphological abnormalities of the basolateral circuit Deakin, J.F.W.
1991
4 3 p. 357-
1 p.
artikel
230 Spectral EEG abnormalities following photic driving in schizophrenic patients Jin, Y.
1991
4 3 p. 333-
1 p.
artikel
231 Spin-spin relaxation time (T2) in schizophrenia Pandurangi, A.
1991
4 3 p. 408-409
2 p.
artikel
232 Striatal-thalamic disorder of cerebral metabolism in never-medicated schizophrenics Buchsbaum, M.S.
1991
4 3 p. 401-
1 p.
artikel
233 Structural brain imaging in partial trisomy chromosome 5 with schizophrenia Honer, W.G.
1991
4 3 p. 278-
1 p.
artikel
234 Studies in skin fibroblasts from chronic schizophrenic patients Mahadik, S.P.
1991
4 3 p. 372-373
2 p.
artikel
235 Suicide as a risk factor for tardive dyskinesia Sandyk, R.
1991
4 3 p. 366-
1 p.
artikel
236 Suicide behavior in patients with schizophrenia Asnis, G.M.
1991
4 3 p. 375-
1 p.
artikel
237 Suicide in schizophrenia: What do we know? where do we go? Wagman, A.M.I.
1991
4 3 p. 378-379
2 p.
artikel
238 Suicide in young adults with schizophrenic disorders: A prospective study Cohen, L.J.
1991
4 3 p. 375-376
2 p.
artikel
239 Tardive dyskinesia in the mentally retarded: Prevalence, risk factor and topographic comparison with a schizophrenic population Cohen, S.
1991
4 3 p. 362-
1 p.
artikel
240 Temporal lobe asymmetries as a clue to the aetiology of schizophrenia Crow, T.J.
1991
4 3 p. 402-
1 p.
artikel
241 Ten years of studies on P50 sensory gating: A review and considerations for future studies Adler, L.E.
1991
4 3 p. 329-
1 p.
artikel
242 Testing systems for assessment of negative symptoms in schizophrenia Fenton, W.S.
1991
4 3 p. 256-
1 p.
artikel
243 The ability of schizophrenics to perceive and cope with negative affect Bellack, A.S.
1991
4 3 p. 299-300
2 p.
artikel
244 The atypical neuroleptic, remoxipride, and prolactin response in the treatment of acute schizophrenia Awad, A.G.
1991
4 3 p. 311-
1 p.
artikel
245 The CBF and CMRO2 drug-naive and drug-treated schizophrenia, and presenile dementia: A study using PET Takahashi, H.
1991
4 3 p. 414-
1 p.
artikel
246 The clinical significance of medial temporal lobe hypoplasia in schizophrenia Nasrallah, H.A.
1991
4 3 p. 407-
1 p.
artikel
247 The clinical significance of neurophysiological deficits in schizophrenic patients Braff, D.L.
1991
4 3 p. 331-
1 p.
artikel
248 The 1962 Copenhagen high-risk study: 29 years after Mednick, S.A.
1991
4 3 p. 281-
1 p.
artikel
249 The correlation of the seasonality of schizophrenic births and stillbirths over a fifty-two year time period Torrey, E.F.
1991
4 3 p. 269-
1 p.
artikel
250 The cortical regulation of dopamine system responsivity: A hypothesis regarding its role in the etiology of schizophrenia Grace, A.A.
1991
4 3 p. 345-
1 p.
artikel
251 The deficit syndrome: functional and structural characteristics Buchanan, R.W.
1991
4 3 p. 400-401
2 p.
artikel
252 The effect of a hospital treatment model on the aftercare compliance rates of a SPMI patient group Sullivan, T.B.
1991
4 3 p. 308-
1 p.
artikel
253 The effect of early neuroleptic intervention on the course of schizophrenia Wyatt, R.J.
1991
4 3 p. 297-
1 p.
artikel
254 The effect of ritanserin on slow wave sleep deficits in schizophrenia Benson, K.L.
1991
4 3 p. 330-
1 p.
artikel
255 The effects of clozapine on dopamine, 5-HT, and glutamate release in the rat medial prefrontal cortex Pehek, E.A.
1991
4 3 p. 323-324
2 p.
artikel
256 The impact of neuroleptic medications on the incidence of tardive dyskinesia in an outpatient population Glazer, W.M.
1991
4 3 p. 363-364
2 p.
artikel
257 The influence of cigarette smoking on haloperidol dosing requirements Perry, P.J.
1991
4 3 p. 292-
1 p.
artikel
258 The Maine-Vermont longitudinal project: The world's only replication study over three decades Harding, C.M.
1991
4 3 p. 259-
1 p.
artikel
259 The measurement of unawareness of illness in schizophrenia Amador, X.F.
1991
4 3 p. 248-
1 p.
artikel
260 The neurodevelopmental and adult schizophrenias: Kraepelin lost and Kraepelin found Murray, R.M.
1991
4 3 p. 282-283
2 p.
artikel
261 The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial Awad, A.G.
1991
4 3 p. 311-312
2 p.
artikel
262 The New York high-risk project: Comorbidity of axis I disorders in subjects at high risk for schizophrenia or major affective disorders and in low-risk subjects Erlenmeyer-Kimling, L.
1991
4 3 p. 276-
1 p.
artikel
263 The New York high-risk project: History of study, overview of marker findings to date and prevalence of axis I high and low risk subjects Cornblatt, B.
1991
4 3 p. 275-
1 p.
artikel
264 The pervasiveness of cognitive and behavioral treatment interventions in the schizophrenic's rehabilitation Brenner, H.D.
1991
4 3 p. 301-
1 p.
artikel
265 The pharmacological profile of U-86170F, a dopamine autoreceptor agonist Lahti, R.A.
1991
4 3 p. 320-
1 p.
artikel
266 The predictive utility of schizophrenic symptoms in patients with a recent episode of mania Miklowitz, D.J.
1991
4 3 p. 264-
1 p.
artikel
267 The Queensland follow-up study. Schizo-affective psychosis: Phenomenology and outcome Varghese, F.T.
1991
4 3 p. 270-
1 p.
artikel
268 The scope of the schizophrenic spectrum: results of a family study Maier, W.
1991
4 3 p. 263-
1 p.
artikel
269 The search for novel antipsychotics: Agents with a targeted activity in particular brain regions such as hippocampus—the example of savoxepine Bischoff, S.
1991
4 3 p. 313-314
2 p.
artikel
270 The subjective experience of negative symptoms and body image disturbance in schizophrenia Cutbush, J.
1991
4 3 p. 253-254
2 p.
artikel
271 The validity of wisconsin card sorting test factors as measures of dorsolateral prefrontal cortical function in schizophrenia and alcoholism Sullivan, E.V.
1991
4 3 p. 394-395
2 p.
artikel
272 Thought disorder in the siblings of schizophrenic patients Hall, J.K.
1991
4 3 p. 277-278
2 p.
artikel
273 Time course of psychopathologic and dyskinetic motor changes after blind neuroleptic withdrawal Dixon, L.
1991
4 3 p. 288-
1 p.
artikel
274 Towards DSM-IV schizophrenia: The application of three proposed schemata to prospectively collected data Copolov, D.L.
1991
4 3 p. 252-253
2 p.
artikel
275 To what degree do negative symptoms and social adaptation influence motivation towards regular participation in group therapy by schizophrenic outpatients? Schmitz-Niehues, B.
1991
4 3 p. 308-
1 p.
artikel
276 Treatment of borderline personality disorder with serotonin 1a agonist and psychotherapy Wolf, M.
1991
4 3 p. 328-
1 p.
artikel
277 Two nonhuman primate social colony models for screening novel antipsychotic candidates Schlemmer Jr., R.F.
1991
4 3 p. 325-326
2 p.
artikel
278 Use of a sigma receptor ligand, BMY 14802, for the treatment of schizophrenia Gewirtz, G.R.
1991
4 3 p. 317-318
2 p.
artikel
279 Using quantitative trait data to discriminate among genetic models of schizophrenia Moldin, S.O.
1991
4 3 p. 281-
1 p.
artikel
280 Validity of the deficit syndrome Carpenter Jr., .T.
1991
4 3 p. 251-252
2 p.
artikel
281 Vocal acoustic correlates of flat affect: Contrast with other negative signs and depression Alpert, M.
1991
4 3 p. 247-248
2 p.
artikel
282 Volumetric measurements of cerebral gray and white matter and cerebrospinal fluid space (CSF) in chronic schizophrenic patients and controls Woods, B.T.
1991
4 3 p. 414-
1 p.
artikel
283 Weight gain in clozapine treated schizophrenics Lamberti, J.S.
1991
4 3 p. 320-321
2 p.
artikel
284 Why isn't schizophrenia disappearing in Nottingham? Harrison, G.
1991
4 3 p. 259-
1 p.
artikel
285 2-year-outcome of intermittent vs. maintenance neuroleptic treatment in schizophrenia Gaebel, W.
1991
4 3 p. 288-289
2 p.
artikel
                             285 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland